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KEY MESSAGE
 Frequent attenders require a disproportionate amount of GPs’ time and convincing evidence of effectiveness
of treatments is lacking. Thirteen newly identified trials since 2008 did not change this situation much.
Tailored treatment based on in-depth analysis of reasons for frequent attendance by a team of GPs may
decrease consultation frequency.
ABSTRACT
Background: Patients visiting their GPs exceptionally often (frequent attenders, FAs) have high
rates of somatic disease, emotional distress, psychiatric illnesses and social problems and require
a disproportionate amount of their GPs’ time.
Objectives: To summarize which types of FA have been studied and what the effects of interven-
tions were on quality of life (QoL), symptom severity of underlying illness(es) and consultation fre-
quency. To discover when patients are considered FAs.
Methods: Systematic review of RCTs using a comprehensive search (MEDLINE, PsycINFO, CINAHL
and EMBASE, from 1980 to August 2015) and no language restrictions. Two investigators
extracted data. Results were summarized qualitatively.
Results: We included 17 RCTs. Heterogeneity at the level of populations, interventions and out-
comes precluded statistical pooling. In-depth analysis by GPs assessing a patient’s reasons for fre-
quent attendance decreased consultation frequency by four to six per year. A small effect on
symptom severity was noted in depressed FAs, although this finding was not replicated in a
recent trial. Multi-component therapy and medication in FAs with medically unexplained symp-
toms (MUS) improved QoL (SF36 odds ratio: 1.92; 95%CI: 1.08–3.40) and morbidity (CES-D 3.17;
95%CI: 1.27–5.08).
Conclusion: RCTs on intervention effects in frequent attenders to primary care used different
patient populations, interventions, comparators and outcome measures. Consistent evidence on
the effects of particular interventions in specific patient domains is lacking. A tailored approach
based on in-depth analysis among GPs of potential reasons for frequent attendance may
decrease consultation frequency. Research involving the screening and treating for FAs with MUS
may be useful in future trials.
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Introduction
Since the 1960s, it has been observed that the general
practitioner (GP) sees a proportion of his or her regis-
tered patients, frequently.[1–3] In particular, GPs spend
almost 40% of their time on 10% of their patients.[4]
Studies consistently report that the majority of these
frequent attenders (FAs) have mental health problems,
emotional distress and/or social difficulties, mostly
on top of physical illness.[5,6] Chronic somatic and
psychiatric illnesses are usually accepted reasons for
frequent consultation. Temporary crises pass and may
be a reason for brief periods of frequent consultation.
Research shows that regression to the mean occurs,
and only one out of seven patients remain FAs for
three consecutive years.[4] However, frequent attend-
ance by multi-problem patients with undetected
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psychiatric morbidity may trigger many consultations
and lead to ineffective healthcare and persistent fre-
quent attendance.[7] Persistent FAs ( 3 consecutive
years of attendance ranking in the (sex-age adjusted)
top 10%) make up about 1.6% of all enlisted patients,[4]
implying that in The Netherlands an average GP has
some 40 patients who consult very often over extended
periods of time. GPs may perceive this as an important
burden. Moreover, persistent frequent attendance is
associated with major healthcare spending in primary
and specialist healthcare.[8] If effective treatments exist,
detection and treatment of morbidities could improve
FAs’ quality of life (QoL) and lower the impact of fre-
quent attendance on the healthcare system.[4,9]
Unfortunately, interpretation and comparison of studies
on frequent attendance are difficult because of their
heterogeneous characteristics and different
definitions.[5]
Smits et al., in 2008, systematically reviewed inter-
ventions on frequent attenders in primary care and
found five randomized controlled trials (RCTs) describ-
ing interventions on FAs.[11] They found no convincing
evidence that any intervention improves quality of life
(QoL), morbidity or healthcare utilization of FAs. In the
meantime, new RCTs have been published, and an
updated review seems indicated. We wanted to answer
the following questions:
1. Which interventions in FAs were studied in RCTs?
2. Which types of FAs were studied, and how were
FAs defined?
3. What were the intervention effects on QoL, severity
of symptoms or underlying illness(es) (morbidity)
and consultation frequency?
Methods
We used acknowledged review methodology and
reported according to PRISMA.[12]
Eligibility criteria
We accepted all definitions of the term ‘frequent
attender’. We defined primary care as all first points of
consultation sites, not-in-hospital care. We included
only RCTs. No language restrictions were used, and we
accepted all possible interventions as long as a (usual
care) control group was available.
Literature search
We searched EMBASE, MEDLINE, PsycINFO and CINAHL
between 1 January 1980 and 13 August 2015 using a
dedicated search strategy designed by a clinical
librarian (FvE; see Appendix 1 in Supplementary
Material, available online). Also, we checked the
references of all included articles for additional rele-
vant articles.
Selection of articles
Stage 1. Two authors (GtR and DH) separately screened
the first 200 hits and then discussed them, which
made DH become familiar with this type of research.
One author (DH) screened the rest of the titles and
abstracts against the inclusion criteria. In the latest
search, covering the period between January 1980 and
August 2015, both authors evaluated all new hits inde-
pendently. Disagreements were resolved by consensus.
When there was doubt about the setting or the patient
population, we assessed the full paper.
Stage 2. Full-text papers were retrieved for all stud-
ies considered to meet the inclusion criteria, and two
authors (GtR and DH) independently assessed if they
indeed met the inclusion criteria. Two authors (GtR
and DH) independently extracted the data. Consensus
resolved disagreements.
Quality assessment
One author (DH) appraised the quality of each RCT
using a dedicated checklist.[13] This checklist consisted
of nine methodological items scored as yes, no, or
uncertain (Table 21). A second author (GtR) independ-
ently checked the quality assessments, which DH indi-
cated as difficult to assess. Disagreements were
resolved by consensus.
Results
Selection of articles
The search yielded 1098 articles of which 17 were
included. In an update of the search, an additional 253
articles were found, but no new eligible RCTs. Figure 1
shows a full flowchart.
Population and types of frequent attenders
The included studies targeted diverse types of FAs
(Table 2). Three studies enrolled older FAs in health
maintenance organizations (HMO) in the USA.[16,27,29]
Three authors targeted depressed FAs.[17,18,26] One
study targeted FAs with general mental health prob-
lems.[24] Six trials studied FAs with medically unex-
plained symptoms (MUS) or somatization.
[19,21–23,30–31] Three studies did not define a specific
type of FAs.[20,25,28] One study used students attend-
ing a university health centre.[14] Another study tar-
geted the so-called ‘distressed FAs’ (those with a sum
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score 1 standard deviation above population mean on
the symptom checklist—revised).[15]
Definitions of frequent attenders
Definition of FA varied considerably. In particular, three
studies used pre-set centiles of the attendance
distribution. Thirteen used a cut-off number, ranging
from 5–24 consultations per year (we normalized the
number of consultations to a period of one year).
Some authors chose this number based on the mean
visit frequency for the (sub)group or clinic. One author
used a ‘healthcare utilization algorithm’ to select
FAs.[29] The time window, in which the consultation
Figure 1. Study selection flow chart. 1Because of time constraints, one author (DH) assessed and screened most of the articles of
stage I. Discordances were solved based on consensus. 2Two studies refer to the same trial.
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frequencies were assessed, also differed from three
months to three years.[26,28]
Interventions
Table 2 shows a full list of interventions. Interventions
varied considerably per subtype of FA and were listed
by subtype of FAs.
Older FAs. Two out of three studies used a group
intervention. Beck et al. used a group intervention led
by a GP and a nurse consisting of health education, pre-
vention measures such as house safety, exercise, nutri-
tion, and mutual support.[16] Haas et al. compared
health education classes to enhanced mental benefits,
including psychiatric evaluation, psychotherapy visits,
and if needed, medication.[27] Shannon et al. investi-
gated referrals to home and community-based services
(HCBS).[29]
Depressed FAs. All three studies offered a depres-
sion management programme. Katzelnick and Simon
refer to the same research programme.[17,18] They
implemented a depression management programme,
which consisted of a two-hour training, evaluation
contacts, antidepressant medication, information
material, and assignment of a treatment coordinator.
In the third trial, Berghofer et al. assessed a depres-
sion management programme, consisting of a treat-
ment algorithm, pharmacotherapy, standardized
patient-provider education, and physician and patient
counselling.[26]
FAs with MUS or somatoform symptoms. Six studies
targeted these FAs using patient or GP education, dis-
closures of events, acupuncture or cognitive therapy.
Larisch targeted FAs with somatoform symptoms by
offering six 20-min consultations with their GP over six
months.[21] The GPs received 12-h training about treat-
ing somatization (role play, video feedback, using a
reattribution model). Schilte et al. treated FAs using dis-
closure of emotionally important events by FAs in two
or three meetings with a trained ‘disclosure doctor’.[19]
Patients received screening questions and kept a diary
about their experiences. Rasmussen used an hour-long
‘health enhancement consultation’ by a nurse with the
GP present. Medical records were reviewed by two GPs
to assess whether hospitalization was avoidable. Smith
et al. intervened by conducting 12 nurse practitioner-
led 20-min visits using multi-step patient-centred meth-
ods.[22] Treatment included antidepressants, reduction
of ineffective medications, exercise, relaxation/physical
therapy, and physical disease management. Telephone
contact was scheduled between visits. Van Ravesteijn
applied eight 2.5-h mindfulness sessions.[31] Patients
received information about the sessions, homework
assignments and forms to keep a record of their adher-
ence, together with CDs with meditations and exercises.
Paterson et al. applied 12 individual sessions (60min,
over a six-month period) of acupuncture by eight acu-
puncture practitioners.[30]
Distressed FAs. In the only trial that focused on dis-
tressed FAs, a diagnostic Interview schedule and an
interview was performed by a psychiatrist with the GP
present after which a jointly formulated treatment plan
was created for each FA [15]. Schreuders et al., in FAs
with general mental health problems, tested a ‘prob-
lem-solving treatment’ (four to six 2.5–4 h sessions) by
trained nurses, to increase the patients’ understanding
of the relationship between everyday problems and
psychological symptoms.[24]
No specific subtype of FAs. Four studies targeted all
patients identified as FAs. Gidron et al. used a guided
disclosure protocol.[28] Patients wrote (15min for three
days) about their most stressful experience of the past
five years. Controls wrote about neutral topics.
Christensen et al. used a patient questionnaire and an
invitation for the FAs to contact their GP for a status
consultation; information about the project; GP educa-
tion on frequent attending; and economic incentives for
the GP to perform the status consultation.[20] Bellon
et al. applied a ‘7 hypothesisþ team intervention’ after
three GPs received 15-h training in the intervention.[25]
The GPs held meetings to share analyses and reflections
on their FAs and to make tailored plans for each FA.
GPs also received emotional support in these meetings
and helped generate strategies to deal with FAs. Finally,
Olbrisch compared an educational programme aimed at
making students aware of the psychological and social
factors that make people prone to illness and inappro-
priate use of healthcare. It included a question and
answer period and a demonstration of systematic deep
muscle relaxation of which a relaxation tape or an indi-
vidual session was offered.[14]
Quality assessment
Table 1 shows an overview of the quality assessment.
Appendix 2 in Supplementary Material, available
online, lists the full quality assessments in narrative
form.
Study characteristics and effects per outcome
Heterogeneity at the level of patient populations, inter-
ventions and outcomes precluded sensible statistical
pooling of results (See Table 2 for the characteristics
per study.)
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Quality of life
Eight studies measured QoL, of which four were of
high quality (with concealed allocation, intention to
treat analysis and overall high quality). Six studies used
a generic short form scale. One study also used a vis-
ual analogue scale (VAS), two the EuroQol-5D. All stud-
ies targeted specific types of FAs. Two high-quality
studies showed an effect on QoL. Smith et al. inter-
vened by conducting visits using multi-step patient-
centred methods including antidepressants, exercise,
relaxation training, etc. They reported that the inter-
vention group was more likely to improve (SF36) and
the number needed to treat for one patient to improve
was 6.4 (95%CI: 0.89–11.89).[23] Katzelnick et al. inter-
vening in depressed FAs, reported a beneficial effect of
depression management at 12 months on social func-
tioning, mental health and general health perceptions
(SF-20, P< 0.05 for all), but not on physical and role
functioning and pain perception.[17] Participants in the
mindfulness-based cognitive therapy (MBCT) group
reported a greater improvement in mental functioning
at the end of treatment (SF-6D: difference 3.9; 95%CI:
0.24–7.6), but between-group differences disappeared
after nine months.[31] The general health status (EQ-
5D VAS) did not differ at the end of treatment. The
other studies have been summarized in Table 2.
Morbidity
We found 10 studies that assessed symptoms and
(severity of) mental health diseases using various scales,
of which four studies were of high quality. Four authors
reported modest effects in three research programmes
(Katzelnick and Simon referred to the same research
programme [17,18]). They reported that patients in the
intervention group had on average 47/365 more
depression-free days following depression management
(95%CI: 26.6–68.2), showed improvements of 9.2 versus
5.6 on the Hamilton score at 12 months for intervention
and usual care patients, respectively (P< 0.001).
Bergh€ofer, in a more recent trial targeting depressed
FAs, reported no differences on the HAMD-17 at six or
12 months. The intervention group had superior results
after six months (56% reduction of the baseline B-PHQ-
9 sum score versus 17% in controls; P< 0.002) but not
at follow-up [26]. Smith et al. also reported less depres-
sive symptomatology in the treatment group.[23] The
calculated inter-group difference after one year was
1.44 (CES-D, 95%CI: –1.23–4.11) for treatment.
Frequency of attendance
Fifteen studies measured effects on the consultation
frequency. Five RCTs were deemed to be of high
quality. One RCT reported statistically significantly
fewer primary care consultations.[25] Bellon et al.
reported that the ‘7 hypothesisþ team (7Hþ T) inter-
vention’ group (IG) consulted less compared to the
two control groups (C1/C2) after one year.[25] Their
intervention consisted of a group of GPs assessing the
reasons why patients frequently attend. C1 received
usual care by different GPs. C2 received usual care by
the GPs that also intervened (IG–C1: –6.27, P¼ 0.001;
IG–C2: –3.62, P¼ 0.006). Although Shannon et al., who
intervened in older FAs, reported that the intervention
group was more likely than controls to use GP services
(odds ratio (OR): 2.05; P< 0.001), the number of hos-
pital admissions (OR: 0.43; P< 0.01) and hospital days
(OR: 0.39, P< 0.05) were more stable in the interven-
tion group which was offered referrals and regular
assessments.[29] Ravesteijn et al., who intervened in
FAs with MUS using mindfulness-based cognitive ther-
apy, found no difference between the consultation fre-
quencies of both groups.[31] Simon and Katzelnick
reported that the depression management programme,
which targeted depressed FAs, resulted in more
attendance in the intervention group (þ1.6 versus -2.0,
P¼ 0.02).[17,18] For the effects on consultation fre-
quency on the other studies, see Table 2.
Discussion
Main findings
Large heterogeneity at the levels of interventions,
study populations and outcome measures precluded
combination of results across 17 RCTs in FAs of pri-
mary care. A few trials stood out: Katzelnick et al. and
Simon et al. reported modest improvements in QoL
and depression-free days using a depression manage-
ment programme, the effect on morbidity was how-
ever not replicated in a recent trial.[17,18,26] Bellon
et al., using a patient-tailored approach, reported a
modest reduction of consultations.[25] Smith et al.,
using multi-step patient-centred methods, reported
modest improvement of QoL and morbidity in FAs
with MUS.[23]
Strengths and limitations
To our knowledge, this systematic review is currently
the most comprehensive review of interventions on
FAs. We used acknowledged methodology and
reported according to PRISMA.[12] We updated our
previous systematic review using a more comprehen-
sive search strategy developed by an experienced
librarian (FvE) and found 13 additional trials.[11] This
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could be attributed to not using proximity keywords in
a previous review by our team. The enormous variation
in FA definition, patient selection methods across trials
and settings, however, precluded drawing strong con-
clusions. A limitation of this review is that we took the
effects reported at face value and did not go into
detail about the various conceptual models underlying
the interventions used. Furthermore, theoretically, ran-
domization takes care of prognostic factors across
intervention groups, however, without formally defin-
ing an a priori set of relevant prognostic factors
implies that post-randomization baseline imbalances in
prognostic factors could always be excluded. Although
a review protocol existed, at the time it was not disse-
minated beyond our research group. Another possible
limitation of the current review is that only two investi-
gators screened the first 200 search results obtained
independently. However, we felt that these 200 were
sufficient for DH to become an expert. In addition, the
articles that were selected for detailed reading (n¼ 31)
were assessed independently by two investigators
against the inclusion criteria. The interrater reliability
(Kappa) for this process was 0.718 (SEM: 0.131, 95%CI:
0.461–0.975), suggesting good agreement. In the
update of the search, performed in August 2015, two
independent investigators resulting in no discordances
screened all new hits. Therefore, it is unlikely that we
have missed many RCTs.
Comparison with existing literature
Based on a review in 2008 of five studies, Smits et al.
concluded that ‘no convincing treatment existed that
was effective.’ They noted a small effect in a subgroup
of depressed patients in one trial. Recently, a trial
looked at depressed patients but the (subgroup) effect
reported by Katzelnick and Simon was not repli-
cated.[26] The current review confirms the considerable
heterogeneity at the level of patients, interventions, and
outcome measures reported previously.[11]
Implications for research and practice
Most trials defined FAs using a cut-off based on an
annual number of visits irrespective of sex, age and
physician’s work style. Selection that takes into account
these factors is more appropriate and avoids the risk
of over-representing elderly women.[5,10] Thus, only
selecting the top centiles of the attenders, and stratify-
ing for age and sex may allow for meaningful compari-
sons between countries, interventions, and their
generalization. In their statistical analyses, trialists’
should focus on between-group differences, not on dif-
ferences between baseline and follow-up within
groups. For instance, one study reported less depres-
sion in the treatment group (CES-D), but when we cal-
culated the between-group difference, it was
modest.[23] Also, applying a follow-up period of at
least a year seems indicated, considering that frequent
attending does not always persist.[4] Many FAs suffer
from MUS and more research involving the selection
of FAs and screening, and treating for MUS may be
useful. More research is also needed to replicate and
validate the modest results in the trials we found.
Concerning the high costs of FAs in primary and sec-
ondary care, intervention studies should preferably
include a cost-effectiveness analysis. A programme as
tested by Bellon [25] must be replicated in another
RCT. The cost-effectiveness and cost-utility of this pro-
gramme is currently being tested.[32]. Smith et al.
reported an effect in FAs with MUS.[23] Although
Katzelnick and Simon found a small effect in depressed
FAs, their results have not been replicated.[26]
Conclusion
Frequent attendance is a regular phenomenon in gen-
eral practice and may be a burden to the GP, practice
staff and work-flow. However, it does not seem to
allow for a uniform approach or simple interventional
procedures, but should perhaps be viewed as a trigger
for stratification and differentiation according to indi-
vidual patient’s underlying conditions, adaptive selec-
tion and design of interventions, and professional
staff’s reflection on own attitudes and involvement. In-
depth analysis among GPs assessing a particular
patient’s reasons for frequent attendance and corre-
sponding tailored actions may decrease consultation
frequency. An effect might also be present in FAs with
MUS; however, more rigorously designed trials are
needed to establish this.
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